Joseph P. Hagan, President and CEO at Regulus Therapeutics Inc. (RGLS), bought 439,560 shares at $0.91 ($400K) on 2017-07-25, disclosed to the SEC on 2017-07-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 219,780 | $200K | 50.0% |
| 2 | $0.91 | 219,780 | $200K | 50.0% |
| Total | $0.91 avg | 439,560 | $400K | 100% |
| Filing → |
| RGLS | SELL | 2024-01-18 | $17K | — | Filing → |
| AUPH | SELL | 2023-05-23 | $3K | — | Filing → |
| RGLS | BUY | 2022-01-26 | $22K | — | Filing → |